[1]
M. Vrankar and K. Stanič, MD, PhD, “Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapy”, RO, vol. 52, no. 3, Sep. 2018.